CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-30 | Cummings Keith Lamont Chief Financial Officer | Sale 10b5-1 | −9,960 | $26.52 | $264K | 148,470 |
| 2023-03-30 | Coulie Bernard President and CEO | Sale 10b5-1 | −35,339 | $26.52 | $937K | 274,753 |
| 2023-03-29 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award | +13,593 | 58,540 | ||
| 2023-03-29 | Lefebvre Eric Chief Medical Officer | Grant or award | +21,874 | 157,031 | ||
| 2023-03-29 | Hull Hans Chief Business Officer | Grant or award | +17,578 | 211,000 | ||
| 2023-03-29 | Cummings Keith Lamont Chief Financial Officer | Grant or award | +19,375 | 158,430 | ||
| 2023-03-29 | Coulie Bernard President and CEO | Grant or award | +68,749 | 310,092 | ||
| 2023-03-06 | MCCOURT Thomas A Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-03-06 | Cline Darren S Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-02-03 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $6.22 | $93K | 255,112 |
| 2023-02-03 | Coulie Bernard President and CEO | Sale | −9,738 | $33.36 | $325K | 245,374 |
| 2023-02-03 | Coulie Bernard President and CEO | Sale | −5,262 | $34.08 | $179K | 240,112 |
| 2023-02-03 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 327,262 | ||
| 2023-02-02 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $6.22 | $93K | 255,112 |
| 2023-02-02 | Coulie Bernard President and CEO | Sale | −13,395 | $34.13 | $457K | 241,717 |
| 2023-02-02 | Coulie Bernard President and CEO | Sale | −1,605 | $34.96 | $56K | 240,112 |
| 2023-02-02 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 342,262 | ||
| 2023-02-01 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $6.22 | $93K | 255,112 |
| 2023-02-01 | Coulie Bernard President and CEO | Sale | −9,455 | $34.15 | $323K | 245,657 |
| 2023-02-01 | Coulie Bernard President and CEO | Sale | −5,440 | $34.78 | $189K | 240,217 |
Page 9 of 19 · 379 trades